HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2369800Generated: October 30, 2026
epsilon-tert-Butyloxycarbonyl-lysine → HCID 87554045, compound
https://huagongshe.com/reaction/2369800
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | epsilon-tert-Butyloxycarbonyl-lysine | HCID 2733284 | — |
| Reactant | 2-(2,5-Dioxopyrrolidin-1-yl)-1,1,3,3-tetramethylisouronium tetrafluoroborate | HCID 9857522 | — |
| Reactant | 16-(Tert-butoxy)-16-oxohexadecanoic acid | HCID 57817723 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 87554045 | HCID 87554045 | — |
Reaction Steps
Hexadecanedioic acid mono-tert-butyl ester can be activated with TSTU in similar fashion to the method described in Example 1, Step 6. The product can be reacted with Boc-Lys-OH in DMF at RT for 16 h. After concentrating under vacuum, AcOEt can be added the residue and the mixture can be washed with 0.2 N HCl. The organic phase is then dried over MgSO4 and concentrated under vacuum to yield the crude product, 15-((S)-5-tert-Butoxycarbonylamino-5-carboxypentylcarbamoyl)pentadecanoic acid tert-butyl ester. This can either be used without further purification or purified by flash chromatography. This compound can be activated with TSTU in similar fashion to the method described in Example 1, Step 6 to yield 15-[(S)-5-tert-butoxycarbonylamino-5-(2,5-dioxopyrrolidin-1-yloxycarbonyl) pentylcarbamoyl]pentadecanoic acid tert-butyl ester, and this compound can be coupled to insulin and deprotected to yield the title compound as described in Example 1, Step 7 using prepatative HPLC to isolate the product.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08710000B2 |
|---|
| Source dataset | uspto-grants-2014_04 |
|---|
| ORD ID | ord-561880c8f4c34575ada51a40348d4d41 |
|---|
| Source note | uspto-grants-2014_04 |
|---|